0001759143-23-000001.txt : 20230331 0001759143-23-000001.hdr.sgml : 20230331 20230331122112 ACCESSION NUMBER: 0001759143-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230331 DATE AS OF CHANGE: 20230331 EFFECTIVENESS DATE: 20230331 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Stingray Therapeutics, Inc. CENTRAL INDEX KEY: 0001759143 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-477596 FILM NUMBER: 23785563 BUSINESS ADDRESS: STREET 1: TMCX - TEXAS MEDICAL CENTER ACCELERATOR STREET 2: 2450 HOLOCOMBE BLVD EAST, SUITE X CITY: HOUSTON STATE: TX ZIP: 77021 BUSINESS PHONE: 713-503-7707 MAIL ADDRESS: STREET 1: TMCX - TEXAS MEDICAL CENTER ACCELERATOR STREET 2: 2450 HOLOCOMBE BLVD EAST, SUITE X CITY: HOUSTON STATE: TX ZIP: 77021 D 1 primary_doc.xml X0708 D LIVE 0001759143 Stingray Therapeutics, Inc. TMCX - TEXAS MEDICAL CENTER ACCELERATOR 2450 HOLOCOMBE BLVD EAST, SUITE X HOUSTON TX TEXAS 77021 713-503-7707 DELAWARE None None Corporation true Jonathan P. Northrup TMCx-Texas Medical Center Accelerator 2450 Holcombe Blvd, Suite X Houston TX TEXAS 77021 Executive Officer Director Sunil Sharma TMCx-Texas Medical Center Accelerator 2450 Holcombe Blvd, Suite X Houston TX TEXAS 77021 Executive Officer Director Uma Bhatt TMCx-Texas Medical Center Accelerator 2450 Holcombe Blvd, Suite X Houston TX TEXAS 77021 Executive Officer Director Biotechnology Decline to Disclose 06b false 2023-01-23 false true false 0 5230297 3948445 1281852 Total Amount Sold consists of the cancellation of aggregate amount outstanding under existing convertible notes and amount invested under SAFEs previously issued by the Company. false 43 0 0 0 false Stingray Therapeutics, Inc. /s/ JONATHAN NORTHRUP Jonathan Northrup Chief Executive Officer 2023-03-31